Drugs / Sahasthara
Sahasthara
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06184685 | Oct → Nov 2021 | osteoarthritis, knee | Thammasat University | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Sahasthara | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06184685 ↗ |
| Known as | Sahasthara Microemulsion | “Drug: Sahasthara Microemulsion” NCT06184685 ↗ |
| Known as | SHT-ME | “To assess the safety and effectiveness of Sahasthara microemulsion (SHT-ME) in comparison to a diclofenac microemulsion (DF-ME) in treating primary osteoarthritis (OA) of the knee.” NCT06184685 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Sahasthara is a traditional Thai herbal remedy” NCT06184685 ↗ |